Generate Biomedicines, Inc. · NASDAQ:GENB
Generate Biomedicines, Inc. shareholders
As of Sep 30, 2026, 104 institutions reported holding Generate Biomedicines, Inc., 82.7% of its shares. Largest: Flagship Pioneering, LLC, Fidelity and Capital Group. New holders, exits, insiders and big stakes, each with its filing.
Shareholders
Institutions
| Holder | Shares | Of the company | Value | Change vs Jun 30 | Filed |
|---|---|---|---|---|---|
| Flagship Pioneering, LLC | 62.7M | 48.5% | US$941M | No change | Nov 16, 2026 |
| Fidelity | 7.19M | 5.6% | US$108M | +1.96M | Nov 10, 2026 |
| Capital Group | 4.2M | 3.3% | US$63.1M | −13,642 | Nov 12, 2026 |
| Braidwell LP | 2.96M | 2.3% | US$44.5M | −322K | Nov 16, 2026 |
| JPMorgan | 2.65M | 2.1% | US$40.9M | +1.25M | Nov 12, 2026 |
| Vanguard | 2.62M | 2.0% | US$39.3M | +1.13M | Nov 13, 2026 |
| Deep Track Capital, LP | 2.51M | 1.9% | US$37.7M | +1.17M | Nov 16, 2026 |
| ARK | 1.96M | 1.5% | US$29.5M | +680K | Nov 13, 2026 |
| ARCH Venture Management, LLC | 1.94M | 1.5% | US$29.2M | No change | Nov 16, 2026 |
| BlackRock | 1.83M | 1.4% | US$27.5M | +170K | Nov 13, 2026 |
| Banque Pictet & Cie SA | 1.77M | 1.4% | US$26.6M | New | Oct 16, 2026 |
| HarbourVest Partners LLC | 1.72M | 1.3% | US$25.9M | No change | Nov 16, 2026 |
| Baker Bros. Advisors LP | 1.42M | 1.1% | US$21.4M | No change | Nov 16, 2026 |
| T. Rowe Price | 1.34M | 1.0% | US$20.1M | −819K | Nov 16, 2026 |
| ArrowMark Colorado Holdings LLC | 1.11M | 0.86% | US$16.7M | New | Nov 16, 2026 |
| Nvidia Corp | 833K | 0.65% | US$12.5M | No change | Nov 16, 2026 |
| Davern Capital Partners, LP | 825K | 0.64% | US$12.4M | No change | Nov 12, 2026 |
| Siren, L.L.C. | 736K | 0.57% | US$11.1M | No change | Nov 12, 2026 |
| Geode Capital | 729K | 0.56% | US$11M | −5,920 | Nov 6, 2026 |
| State Street | 546K | 0.42% | US$8.21M | +19,772 | Nov 12, 2026 |
| Millennium | 542K | 0.42% | US$8.14M | +520K | Nov 16, 2026 |
| Morgan Stanley | 522K | 0.40% | US$7.85M | +144K | Nov 13, 2026 |
| Voloridge Investment Management, LLC | 362K | 0.28% | US$5.44M | New | Nov 16, 2026 |
| Schwab | 237K | 0.18% | US$3.57M | +12,814 | Nov 16, 2026 |
| Two Sigma | 205K | 0.16% | US$3.08M | +187K | Nov 16, 2026 |
| Northern Trust | 193K | 0.15% | US$2.9M | −4,171 | Nov 16, 2026 |
| TD | 181K | 0.14% | US$2.78M | +129K | Nov 13, 2026 |
| Alps Advisors Inc | 170K | 0.13% | US$2.55M | +40,636 | Nov 2, 2026 |
| Goldman Sachs | 146K | 0.11% | US$2.19M | +135K | Nov 16, 2026 |
| Prosight Management, LP | 145K | 0.11% | US$2.17M | New | Nov 13, 2026 |
| Savant Capital, LLC | 139K | 0.11% | US$2.09M | New | Nov 5, 2026 |
| UBS | 127K | 0.10% | US$1.91M | −199K | Nov 16, 2026 |
| LMR Partners LLP | 126K | 0.10% | US$1.89M | +25,854 | Nov 16, 2026 |
| Seven Grand Managers, LLC | 125K | 0.10% | US$1.88M | No change | Nov 16, 2026 |
| Quadrature Capital Ltd | 120K | 0.09% | US$1.81M | +88,791 | Nov 13, 2026 |
| Barclays | 118K | 0.09% | US$1.78M | +1,572 | Nov 6, 2026 |
| Manufacturers Life Insurance Company, The | 116K | 0.09% | US$1.74M | +31,190 | Nov 13, 2026 |
| Affinity Asset Advisors, LLC | 100K | 0.08% | US$1.5M | −300K | Nov 13, 2026 |
| Ameriprise | 85,567 | 0.07% | US$1.29M | −5,533 | Nov 16, 2026 |
| Nuveen | 85,281 | 0.07% | US$1.28M | +40,811 | Nov 10, 2026 |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 84,959 | 0.07% | US$1.28M | +47,733 | Nov 13, 2026 |
| Gsa Capital Partners LLP | 81,618 | 0.06% | US$1.23M | New | Nov 16, 2026 |
| Amova Asset Management Americas, Inc. | 78,531 | 0.06% | US$1.18M | +40,313 | Nov 13, 2026 |
| Sumitomo Mitsui Trust Group, Inc. | 78,531 | 0.06% | US$1.18M | +39,866 | Oct 29, 2026 |
| Bank Pictet & Cie (Europe) AG | 77,778 | 0.06% | US$1.17M | New | Oct 20, 2026 |
| BNP Paribas | 62,520 | 0.05% | US$939K | +58,720 | Nov 12, 2026 |
| Aquatic Capital Management LLC | 60,158 | 0.05% | US$904K | New | Nov 16, 2026 |
| BNY | 59,364 | 0.05% | US$892K | +2,038 | Nov 5, 2026 |
| XTX Topco Ltd | 51,762 | 0.04% | US$777K | +26,806 | Nov 16, 2026 |
| Susquehanna | 45,445 | 0.04% | US$683K | +33,823 | Nov 16, 2026 |
This page holds 50 of 104 holders.
Funds
| Holder | Shares | Of the company | Value | Change | As of |
|---|---|---|---|---|---|
| SMALLCAP World Fund Inc | 3.75M | 2.9% | US$63.3M | +103K | Jun 30, 2026 |
| ARK Genomic Revolution ETF | 1.24M | 0.96% | US$17.3M | +734K | Jul 31, 2026 |
| Vanguard Total Stock Market Index Fund | 817K | 0.63% | US$13.8M | +720K | Jun 30, 2026 |
| Fidelity Growth Company Fund | 635K | 0.49% | US$8.33M | New | May 31, 2026 |
| iShares Russell 2000 ETF | 618K | 0.48% | US$10.4M | New | Jun 30, 2026 |
| JPMorgan Small Cap Growth Fund | 580K | 0.45% | US$9.79M | −16,222 | Jun 30, 2026 |
| T. Rowe Price Health Sciences Fund, Inc. | 315K | 0.24% | US$5.31M | +49,323 | Jun 30, 2026 |
| Eaton Vance Worldwide Health Sciences Fund | 313K | 0.24% | US$4.1M | New | May 31, 2026 |
| Vanguard Extended Market Index Fund | 296K | 0.23% | US$5M | +265K | Jun 30, 2026 |
| Fidelity Small Cap Index Fund | 267K | 0.21% | US$3.74M | New | Jul 31, 2026 |
| JPMorgan Small Cap Blend Fund | 184K | 0.14% | US$3.11M | −8,323 | Jun 30, 2026 |
| Fidelity Growth Company K6 Fund | 177K | 0.14% | US$2.33M | New | May 31, 2026 |
| American Funds U.S. Small & Mid Cap Equity Fund | 174K | 0.14% | US$2.29M | New | May 31, 2026 |
| Fidelity Series Growth Company Fund | 169K | 0.13% | US$2.22M | New | May 31, 2026 |
| iShares Russell 2000 Growth ETF | 158K | 0.12% | US$2.66M | New | Jun 30, 2026 |
| SMALLCAP World Fund | 104K | 0.08% | US$1.75M | New | Jun 30, 2026 |
| Multi-Manager Small Cap Equity Strategies Fund | 91,964 | 0.07% | US$1.21M | New | May 31, 2026 |
| Fidelity Nasdaq Composite Index Fund | 77,069 | 0.06% | US$1.01M | New | May 31, 2026 |
| iShares Russell 2000 Value ETF | 66,087 | 0.05% | US$1.11M | New | Jun 30, 2026 |
| JPMorgan U.S. Small Company Fund | 59,616 | 0.05% | US$1.01M | −332K | Jun 30, 2026 |
| Schwab Small-Cap Index Fund | 59,231 | 0.05% | US$829K | New | Jul 31, 2026 |
| Small Cap Value Fund | 53,186 | 0.04% | US$698K | New | May 31, 2026 |
| Master Small Cap Index Series | 45,633 | 0.04% | US$770K | New | Jun 30, 2026 |
| Fidelity Nasdaq Composite Index ETF | 41,854 | 0.03% | US$549K | New | May 31, 2026 |
| Nuveen Small Cap Blend Index Fund | 32,382 | 0.03% | US$453K | New | Jul 31, 2026 |
| U.S. Small and Mid Cap Equity Fund | 26,842 | 0.02% | US$453K | −12,873 | Jun 30, 2026 |
| EQ/2000 Managed Volatility Portfolio | 26,125 | 0.02% | US$441K | New | Jun 30, 2026 |
| Schwab Total Stock Market Index Fund | 25,592 | 0.02% | US$358K | New | Jul 31, 2026 |
| Virtus Biotech Clinical Trials Etf | 25,106 | 0.02% | US$351K | New | Jul 31, 2026 |
| Select Biotechnology Portfolio | 21,800 | 0.02% | US$286K | New | May 31, 2026 |
| Health Sciences Trust | 19,277 | 0.01% | US$325K | +1,043 | Jun 30, 2026 |
| T. Rowe Price Health Sciences Portfolio | 19,115 | 0.01% | US$322K | +3,072 | Jun 30, 2026 |
| LVIP State Street Small-Cap Index Fund | 17,700 | 0.01% | US$299K | New | Jun 30, 2026 |
| Blackstone Alternative Multi-Strategy Fund | 16,438 | 0.01% | US$277K | −1,262 | Jun 30, 2026 |
| Fidelity Small Cap Growth Index Fund | 15,724 | 0.01% | US$265K | New | Jun 30, 2026 |
| Vanguard Institutional Total Stock Market Index Fund | 14,889 | 0.01% | US$251K | +13,416 | Jun 30, 2026 |
| EQ/T.Rowe Price Health Sciences Portfolio | 13,453 | 0.01% | US$227K | +753 | Jun 30, 2026 |
| LVIP JPMorgan Small Cap Core Fund | 13,304 | 0.01% | US$224K | −72,623 | Jun 30, 2026 |
| Small Cap Index Fund | 12,605 | <0.01% | US$213K | New | Jun 30, 2026 |
| Global X Russell 2000 ETF | 11,616 | <0.01% | US$163K | New | Jul 31, 2026 |
| Fidelity Small Cap Value Index Fund | 10,571 | <0.01% | US$178K | New | Jun 30, 2026 |
| EQ/Small Company Index Portfolio | 9,550 | <0.01% | US$161K | New | Jun 30, 2026 |
| EQ/AB Small Cap Growth Portfolio | 9,550 | <0.01% | US$161K | New | Jun 30, 2026 |
| Tiff Multi-Asset Fund | 9,229 | <0.01% | US$156K | −24,547 | Jun 30, 2026 |
| ATM Small Cap Managed Volatility Portfolio | 8,949 | <0.01% | US$151K | New | Jun 30, 2026 |
| Vy(R) Jpmorgan Small Cap Core Equity Portfolio | 8,757 | <0.01% | US$148K | −49,578 | Jun 30, 2026 |
| MetLife Russell 2000 Index Portfolio | 8,412 | <0.01% | US$142K | New | Jun 30, 2026 |
| Small-Cap Index Portfolio | 6,910 | <0.01% | US$117K | New | Jun 30, 2026 |
| State Street Small/Mid Cap Equity Index Portfolio | 6,800 | <0.01% | US$115K | New | Jun 30, 2026 |
| Victory Extended Market Index Fund | 6,300 | <0.01% | US$88,200 | New | Jul 31, 2026 |
This page holds 50 of 89 holders.
Big stakes
| Holder | Stake | Shares | Date |
|---|---|---|---|
| Flagship Pioneering, LLC | 48.90% | 62.7M | Mar 31, 2026 |
| FMR LLC | 5.60% | 7.19M | Sep 30, 2026 |
| Nally Michael | 5.20% | 6.92M | Mar 31, 2026 |